中远端血管闭塞血管内治疗效应差异:DISTAL二次分析
该研究基于Bernese卒中登记训练TabPFN模型预测单纯BMT的EENO,并应用于DISTAL随机试验(55中心、11国)患者。模型外部AUC为0.73,预测EENO与治疗效应存在显著交互(P=0.012):预测可EENO者EVT与90天mRS更差相关(cOR 0.48)。仅用入院NIHSS的模型表现相当(AUC 0.71)。
要点
- 预测BMT可EENO者EVT与90天mRS更差相关(cOR 0.48,95%CI 0.27–0.84)。
- 预测不能EENO者未见EVT治疗效应(cOR 1.13,95%CI 0.79–1.60)。
- 仅用入院NIHSS的模型与多变量模型判别力相当(AUC 0.71 vs 0.73)。
核心结论
- 在中远端血管闭塞患者中,预测单纯BMT即可获得EENO者接受EVT与90天mRS更差相关。
- 仅用入院NIHSS的模型判别力与多变量模型相当(AUC 0.71 vs 0.73)。
研究设计与样本
- 在Bernese卒中登记(n=257,42%女性,平均年龄70.4±14.8岁)训练TabPFN模型预测单纯BMT的EENO(24小时NIHSS 0–2)。
- 模型应用于DISTAL随机试验(55中心、11国;270例单纯BMT,269例EVT+BMT;44%女性;平均年龄74.9±12.0岁)。
- 检验预测EENO与治疗分配对主要结局(90天mRS位移)的交互作用,并用入院NIHSS重复分析。
主要发现
- 开发队列中54%达到EENO。
- DISTAL队列中模型外部判别力中等(AUC 0.73)。
- 预测EENO与治疗效应存在显著交互(Pinteraction=0.012)。
- 152例预测可EENO者EVT与90天mRS更差相关(cOR 0.48,95%CI 0.27–0.84)。
- 387例预测不能EENO者未见治疗效应(cOR 1.13,95%CI 0.79–1.60)。
关键数值与推荐
- 仅用入院NIHSS模型AUC 0.71;NIHSS≤4者EVT的cOR 0.47(95%CI 0.25–0.89),NIHSS>4者cOR 1.05(95%CI 0.75–1.47),Pinteraction=0.029。
临床怎么用
- 对中远端血管闭塞患者,可用预测模型或入院NIHSS识别单纯BMT即可能EENO者,此类患者接受EVT可能有害。
- 入院NIHSS≤4可能作为提示EVT harm的简易筛选指标,需结合临床综合判断。
局限性
- 为DISTAL试验的二次分析,预测模型为外部开发。
- 模型外部判别力仅为中等(AUC 0.73)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Stroke, Ahead of Print. BACKGROUND:Patients with medium or distal vessel occlusion stroke are heterogeneous. Randomized trials show no net benefit of endovascular treatment (EVT) over best medical treatment (BMT) alone, which may mask heterogeneity of treatment effect. We used an externally developed machine learning model to predict excellent early neurological outcome (EENO) with BMT alone and examined whether the effect of EVT differed across predicted risk.METHODS:A Tabular Prior-Data Fitted Network (TabPFN) model was trained to predict EENO (24-hour National Institutes of Health Stroke Scale [NIHSS] score of 0–2) in patients with medium or distal vessel occlusion treated with BMT alone in a local Bernese Stroke Registry. This model was applied to patients from the DISTAL randomized trial (55 centers and 11 countries), who were randomized to EVT plus BMT or BMT alone. We tested for interaction between predicted EENO and treatment allocation on the primary outcome (90-day modified Rankin Scale shift), repeating this using admission NIHSS alone.RESULTS:In the development cohort (n=257, 42% female, and mean age 70.4±14.8 years), 54% achieved EENO. In the DISTAL cohort (270 BMT alone, 269 EVT plus BMT, 44% female, and mean age 74.9±12.0 years), the model showed moderate external discrimination (area under the receiver operating characteristic curve 0.73). A significant interaction was found between predicted EENO and treatment effect (Pinteraction=0.012): in 152 patients predicted to achieve EENO, EVT was associated with worse 90-day modified Rankin Scale score (common odds ratio, 0.48 [95% CI, 0.27–0.84]), whereas no treatment effect was seen in 387 patients predicted not to achieve EENO (common odds ratio 1.13 [95% CI, 0.79–1.60]). A model using admission NIHSS alone showed comparable discrimination (area under the receiver operating characteristic curve 0.71) and a common odds ratio for EVT of 0.47 (95% CI, 0.25–0.89) in patients with an NIHSS score of ≤4 and a common odds ratio of 1.05 (95% CI, 0.75–1.47) in patients with an NIHSS score of >4 (Pinteraction=0.029).CONCLUSIONS:EVT was harmful in patients with medium or distal vessel occlusion predicted to achieve EENO with BMT alone, and an NIHSS-alone model performed comparably to the multivariable model.REGISTRATION:URL:https://www.clinicaltrials.gov; Unique identifier: NCT05029414.
引用
- Stroke:Differential Effect of Endovascular Treatment in Medium or Distal Vessel Occlusion: A Distal Secondary Analysis
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。